Home > Insider Trading > Filing (0001209191-14-018016)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411158	Anacor Pharmaceuticals Inc.	ANAC	Pharmaceutical Preparations (2834)	251854385

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1105941	P David Perry	C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-03-04	7,500	$20.20	418,806	No	4	S	Direct
Common Stock	Disposition	2014-03-04	50,000	$20.22	368,806	No	4	S	Direct
Common Stock	Disposition	2014-03-05	7,500	$20.24	361,306	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopetd by the reporting person on November 19, 2013.
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.995 to $20.40, inclusive.
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive.
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.14 to $20.39, inclusive.